IDEAYA Biosciences, Inc. (IDYA)
34.51
-0.33
(-0.95%)
USD |
NASDAQ |
Dec 30, 16:00
33.90
-0.61
(-1.77%)
After-Hours: 20:00
IDEAYA Biosciences EPS Diluted (Quarterly): 1.330 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Rezolute, Inc. | -0.1755 |
| GT Biopharma, Inc. | -0.8268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 119.24M |
| Revenue (Quarterly) | 207.83M |
| Total Expenses (Quarterly) | 88.59M |
| Enterprise Value | 2.266B |
| Gross Profit Margin (Quarterly) | 99.50% |
| Profit Margin (Quarterly) | 57.37% |
| Earnings Yield | -5.38% |
| Normalized Earnings Yield | -5.376 |